Have your own idea? Try our Stock Screener
Hong Kong (HSI) Biotech Industry Analysis
UpdatedApr 03, 2026
DataAggregated Company Financials
Companies63
- 7D15.5%
- 3M16.5%
- 1Y69.0%
- YTDn/a
Over the last 7 days, the Biotech industry has risen 13%, and Innovent Biologics contributed the most with a gain of 15%. In the same time, Ab&B Bio-Tech JS was down 12%. In the last 12 months, the industry was up 64%. As for the next few years, earnings are expected to grow by 31% per annum.
Industry Valuation and Performance
Has the Hong Kong Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 03 Apr 2026 | HK$1.1t | HK$92.6b | -HK$3,837,008,620.40 | 31.8x | -296x | 12.3x |
| Sun, 01 Mar 2026 | HK$970.1b | HK$71.5b | -HK$14,450,268,627.81 | 35.3x | -67.1x | 13.6x |
| Tue, 27 Jan 2026 | HK$969.0b | HK$70.2b | -HK$13,956,449,414.96 | 33.4x | -69.4x | 13.8x |
| Thu, 25 Dec 2025 | HK$956.5b | HK$69.8b | -HK$13,767,198,439.97 | 39.1x | -69.5x | 13.7x |
| Sat, 22 Nov 2025 | HK$970.7b | HK$69.0b | -HK$12,857,404,678.83 | 38.4x | -75.5x | 14.1x |
| Mon, 20 Oct 2025 | HK$1.0t | HK$68.3b | -HK$13,105,232,689.35 | 55.1x | -78.9x | 15.2x |
| Wed, 17 Sep 2025 | HK$1.2t | HK$68.5b | -HK$13,530,362,334.82 | 49.9x | -85.8x | 17x |
| Fri, 15 Aug 2025 | HK$1.0t | HK$63.8b | -HK$12,737,883,616.92 | 48x | -81.7x | 16.3x |
| Sun, 13 Jul 2025 | HK$788.5b | HK$63.8b | -HK$12,211,400,221.91 | 31.6x | -64.6x | 12.4x |
| Tue, 10 Jun 2025 | HK$707.0b | HK$62.2b | -HK$11,779,646,869.98 | 34.3x | -60x | 11.4x |
| Thu, 08 May 2025 | HK$562.2b | HK$61.1b | -HK$11,936,574,058.48 | 31x | -47.1x | 9.2x |
| Sat, 05 Apr 2025 | HK$539.7b | HK$58.3b | -HK$10,877,887,402.05 | 31x | -49.6x | 9.3x |
| Mon, 03 Mar 2025 | HK$443.5b | HK$52.1b | -HK$17,202,023,185.82 | 17x | -25.8x | 8.5x |
| Wed, 29 Jan 2025 | HK$356.4b | HK$52.3b | -HK$17,398,311,890.15 | 12.3x | -20.5x | 6.8x |
| Fri, 27 Dec 2024 | HK$379.1b | HK$51.8b | -HK$17,223,035,304.34 | 10.8x | -22x | 7.3x |
| Sun, 24 Nov 2024 | HK$387.3b | HK$52.3b | -HK$17,389,276,675.89 | 10.4x | -22.3x | 7.4x |
| Tue, 22 Oct 2024 | HK$400.2b | HK$52.4b | -HK$17,911,065,536.33 | 12x | -22.3x | 7.6x |
| Thu, 19 Sep 2024 | HK$379.0b | HK$52.6b | -HK$18,253,092,300.55 | 10.8x | -20.8x | 7.2x |
| Sat, 17 Aug 2024 | HK$325.6b | HK$51.0b | -HK$19,223,761,250.23 | 11.7x | -16.9x | 6.4x |
| Mon, 15 Jul 2024 | HK$329.5b | HK$49.7b | -HK$19,482,026,112.04 | 12.7x | -16.9x | 6.6x |
| Wed, 12 Jun 2024 | HK$337.8b | HK$49.7b | -HK$19,481,479,995.14 | 10.2x | -17.3x | 6.8x |
| Fri, 10 May 2024 | HK$378.8b | HK$49.9b | -HK$19,284,929,922.34 | 12.4x | -19.6x | 7.6x |
| Sun, 07 Apr 2024 | HK$331.0b | HK$49.3b | -HK$19,506,665,375.55 | 10.2x | -17x | 6.7x |
| Tue, 05 Mar 2024 | HK$352.5b | HK$47.2b | -HK$20,388,952,176.16 | 16.2x | -17.3x | 7.5x |
| Thu, 01 Feb 2024 | HK$306.2b | HK$47.3b | -HK$20,430,384,723.00 | 14.7x | -15x | 6.5x |
| Sat, 30 Dec 2023 | HK$409.4b | HK$47.3b | -HK$20,423,403,763.00 | 17.8x | -20x | 8.7x |
| Mon, 27 Nov 2023 | HK$414.2b | HK$46.3b | -HK$18,673,865,270.00 | 18.9x | -22.2x | 8.9x |
| Wed, 25 Oct 2023 | HK$383.9b | HK$44.9b | -HK$19,087,443,396.00 | 12.9x | -20.1x | 8.6x |
| Fri, 22 Sep 2023 | HK$412.0b | HK$44.9b | -HK$18,904,276,417.00 | 16.5x | -21.8x | 9.2x |
| Sun, 20 Aug 2023 | HK$375.5b | HK$35.8b | -HK$22,939,946,336.00 | 17x | -16.4x | 10.5x |
| Tue, 18 Jul 2023 | HK$411.8b | HK$35.6b | -HK$23,402,891,725.00 | 26x | -17.6x | 11.6x |
| Thu, 15 Jun 2023 | HK$399.1b | HK$35.6b | -HK$23,469,426,477.00 | 25.8x | -17x | 11.2x |
| Sat, 13 May 2023 | HK$442.5b | HK$36.5b | -HK$24,129,908,955.00 | 16.8x | -18.3x | 12.1x |
| Mon, 10 Apr 2023 | HK$442.1b | HK$37.1b | -HK$24,186,857,438.00 | 12.2x | -18.3x | 11.9x |
Price to Earnings Ratio
-18.3x
Current Industry PE
- Investors are optimistic on the Hong Kong Biotechnology industry, and appear confident in long term growth rates.
- The 3-year average PS ratio of 10.1x is lower than the industry's current PS ratio of 12.1x.
Past Earnings Growth
- The earnings for companies in the Biotechnology industry have improved over the last three years.
- Revenues for these companies have grown 36% per year.
- This means that more sales are being generated by these companies overall, and subsequently losses are decreasing too.
Industry Comparison
How does Hong Kong Biotech compare with similar industries?
| HK Market | 1.46% | |
| Healthcare | 11.88% | |
| Biotech | 15.53% | |
| Biotech | 15.53% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 1801 Innovent Biologics | HK$91.50 | 15.2% +HK$21.0b | 82.1% | PE171.7x | |
| 6990 Sichuan Kelun-Biotech Biopharmaceutical | HK$503.50 | 17.8% +HK$17.7b | 62.9% | PS50.2x | |
| 9926 Akeso | HK$140.50 | 13.6% +HK$15.5b | 63.6% | PS37.3x | |
| 9995 RemeGen | HK$115.20 | 30.0% +HK$14.8b | 334.7% | PE79.5x | |
| 1530 3SBio | HK$25.38 | 16.9% +HK$9.1b | 92.3% | PE6.6x |
